Express PharmaWhy Most Extractables & Leachables Studies Fail Regulatory Review—and How to Fix Them
More than 60% of initial E&L submissions get flagged due to study design, regulatory interpretation, and documentation. Discover how targeted risk assessment, protocol design, and toxicological justification strengthen compliance.
